{
  "folder": "IC-247",
  "content": "{{knowledge objective\n|Identifiant=OIC-247-08-B\n|Item_parent=Diabetes mellitus type 1 and 2 in children and adults. Complications\n|Item_parent_short=Diabetes mellitus type 1 and 2 in children and adults. Complications\n|Rank=B\n|Title=Knowing the pathophysiology of type 1 diabetes mellitus (T1DM), including in children.\n|Description=including elements of genetic predisposition\n|Topic=Physiopathology\n|Contributors=Eva Feigerlova\n|Order=8}}\n\nType 1 diabetes is characterised by a lack of insulin secretion by the pancreas as a result of autoimmune destruction of pancreatic beta cells.\n\nSeveral factors are involved in the pathophysiology:\n\n- genetic predisposition\n\n- environmental factors\n\n- autoimmune processes\n\nThe following autoantibodies are used as markers of autoimmune disease:\n\n- anti-islanding (ICA),\n\n- anti-insulin (in children)\n\n- anti-GAD (glutamic acid decarboxylase)\n\n- anti-IA2 (Islet Antigen Number 2, related to a tyrosine phosphatase)\n\n- anti-ZnT8 (\u03b2-cell zinc transporter).\n\n\nOther autoimmune diseases and/or organ-specific antibodies may be associated with type 1 diabetes: thyroidopathies, slow adrenal insufficiency, gastric atrophy, coeliac disease and vitiligo.\n\n<ref>CEEDMM, 2019</ref>\n<references />",
  "question": {
    "question": "Which of the following autoantibodies is not commonly used as a marker for autoimmune disease in type 1 diabetes mellitus (T1DM)?",
    "option_a": "anti-islanding (ICA)",
    "option_b": "anti-insulin",
    "option_c": "anti-GAD (glutamic acid decarboxylase)",
    "option_d": "anti-HIV",
    "correct_option": "anti-HIV"
  }
}